|
...today. The acquisition now subject only to the approval of AustCancer shareholders at an extraordinary general meeting on July 19th.
Galenica's proprietary technology comprises three families of semi-synthetic immune enhancers, or adjuvants, which are used to stimulate the immune system. Employed as stand-alone therapeutics, or as an essential component in vaccines, these compounds have...
NOTE: All illustrations and photos
have been removed from this article.
More articles from BIOTECH Patent News
Department of Health and Human Services obtains United States patent.(..., June 01, 2004
Millennium obtains United States patent.(Brief Article), June 01, 2004
Cornell obtains United States patent.(Cornell Research Foundation, Inc..., June 01, 2004
Aventis obtains United States patent.(Brief Article), June 01, 2004
Columbia University obtains United States patent.(Brief Article), June 01, 2004
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
